![Elizabeth Garofalo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Garofalo
Director/Board Member at
ACADIA PHARMACEUTICALS INC.
Net worth: 1 M $ as of 30/06/2026
Profile
Dr. Elizabeth A. Garofalo, MD, is an Independent Director at Alector, Inc., an Independent Director at Xenon Pharmaceuticals, Inc., an Independent Director at ACADIA Pharmaceuticals, Inc. and a Principal at EAG Pharma Consulting LLC.
She is on the Board of Directors at Alector, Inc., Xenon Pharmaceuticals, Inc., ACADIA Pharmaceuticals, Inc. and Institute For Advanced Clinical Trials For Children.
Dr. Garofalo was previously employed as a Chairman by Exicure, Inc., a VP & Head-Neuroscience Therapy Area by Astellas Pharma Global Development, Inc., a Global Head-Clinical Development & Senior VP by Novartis International AG, and a Head-Neuroscience & Worldwide Regulatory Affairs by Pfizer Inc. She received her undergraduate degree from Purdue University and a doctorate degree from The Indiana University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/05/2026 | 33,489 ( 0.02% ) | 847 272 $ | 30/06/2026 | |
ALECTOR, INC. 0.11% | 17/06/2026 | 118,650 ( 0.11% ) | 238 487 $ | 30/06/2026 |
| 03/06/2026 | 2,645 ( 0% ) | 159 652 $ | 30/06/2026 |
Elizabeth Garofalo active positions
| Companies | Position | Start |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Director/Board Member | 29/09/2020 |
| XENON PHARMACEUTICALS INC. | Director/Board Member | 03/06/2021 |
| ALECTOR, INC. | Director/Board Member | 28/09/2021 |
EAG Pharma Consulting LLC | Corporate Officer/Principal | 01/01/2016 |
Institute For Advanced Clinical Trials For Children
 Institute For Advanced Clinical Trials For Children Miscellaneous Commercial ServicesCommercial Services The Institute For Advanced Clinical Trials For Children was a nonprofit organization dedicated to improving pediatric drug development by providing resources and support for efficient, effective pediatric clinical trials. The private company is based in Rockville. It collaborated with strategic partners including major children’s hospitals and universities, offered educational webinars, and published research on pediatric clinical trial methodologies and regulatory topics. The American company was founded by Caroline D. Dorsa. Alexandre P. LeBeaut has been the CEO of the company since 2021. | Director/Board Member | - |
Former positions of Elizabeth Garofalo
| Companies | Position | End |
|---|---|---|
| EXICURE, INC. | Chairman | 24/02/2023 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
Training of Elizabeth Garofalo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
35
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
The Indiana University School of Medicine
 The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure, Inc.
 Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
Institute For Advanced Clinical Trials For Children
Institute For Advanced Clinical Trials For Children Miscellaneous Commercial ServicesCommercial Services The Institute For Advanced Clinical Trials For Children was a nonprofit organization dedicated to improving pediatric drug development by providing resources and support for efficient, effective pediatric clinical trials. The private company is based in Rockville. It collaborated with strategic partners including major children’s hospitals and universities, offered educational webinars, and published research on pediatric clinical trial methodologies and regulatory topics. The American company was founded by Caroline D. Dorsa. Alexandre P. LeBeaut has been the CEO of the company since 2021. | Commercial Services |
EAG Pharma Consulting LLC |
- Stock Market
- Insiders
- Elizabeth Garofalo
Choose MarketScreener 
